# AZothBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/azothbio

- Industry: Pharmaceuticals
- Headquarters: Seongnam, South Korea
- Website: www.azothbio.com
- Total disclosed funding: $5.5M
- Latest round: Series A (Dec 10, 2020)
- Investors on record: 2

## About

Founded in 2016 and based in Seongnam, South Korea, AZothBio Inc. is a pharmaceutical company that researches and develops new small and macromolecular drugs using phenotypic screening. AZothBio Inc. also produces medical products for scar treatments such as biomedical adhesives.

## Funding rounds

- Series A, Dec 10, 2020, $5.5M — DB Securities, Emford Equity Partners

## Investors

- DB Securities (https://capitalatlas.ai/funds/db-securities) — Series A
- Emford Equity Partners (https://capitalatlas.ai/funds/emford-equity-partners) — Series A